ENHANCE I.A./I.V. SODIUM HYALURONATE INJECTION FOR HORSES

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

SODIUM HYALURONATE

Available from:

VETOQUINOL AUSTRALIA PTY LTD

INN (International Name):

sodium hyaluronate(10mg/mL)

Pharmaceutical form:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Composition:

SODIUM HYALURONATE UNGROUPED Active 10.0 mg/ml

Units in package:

12x2mL Vls; 1x2mL Syr

Class:

VM - Veterinary Medicine

Manufactured by:

VETOQUINOL

Therapeutic group:

HORSE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT STUD | MARE | PACER | POL

Therapeutic area:

MUSCULOSKELETAL SYSTEM

Therapeutic indications:

NON-INFECTIOUS ACUTE SYNOVITIS

Product summary:

Poison schedule: 4; Withholding period: WHP: Meat: Nil.; Host/pest details: HORSE: [NON-INFECTIOUS ACUTE SYNOVITIS]; Poison schedule: 4; Withholding period: ; Host/pest details: HORSE: [NON-INFECTIOUS ACUTE SYNOVITIS]; For treatment of non infectious acute synovitis in horses by intra-articular injection.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

11
For treatment of non-infectious acute synovitis
in horses by intra-articular or intravenous injection.
2 mL single dose syringe
DIRECTIONS FOR USE
Strict aseptic technique should be observed when injecting
ENHANCE I.A. / I.V.
Radiographs should be taken prior to administration to
eliminate joint fractures or advanced degenerative joint
disease. This product does not contain an antimicrobial
preservative. Any solution remaining in the syringe after
administration of the required dose should be discarded.
INDICATIONS: ENHANCE I.A. / I.V. is indicated in the treatment
of
lameness
in
horses
due
to
non-infectious
acute
synovitis possibly associated with early equine degenerative
joint disease.
DOSAGE AND ADMINISTRATION:
INTRA-ARTICULAR ROUTE: The recommended dosage
by the INTRA-ARTICULAR ROUTE is 2 mL (1 syringe – 20 mg).
Treatment may be repeated at weekly intervals for a total
of three treatments. As with any intra-articular procedure,
proper
injection
site
disinfection
and
animal
restraint
are
important.
Excess
joint
fluid
should
be
aseptically
removed prior to intra-articular injection. Care should be
taken not to scratch the cartilage surface with the injection
needle.
Diffuse
swelling
lasting
24
to
48
hours
may
result from movement of the needle while in the joint space.
INTRAVENOUS ROUTE: The recommended dosage
by the INTRAVENOUS ROUTE is 4 mL (2 syringes - 40 mg)
per adult horse (450-500 kg). Treatment may be
repeated
at
weekly
intervals
for
a
total
of
three
treatments.
To achieve best results in cases of intra-articular or
intravenous administration, horses should be rested
during treatment and given 7 days stable rest after
treatment before gradually resuming normal activity.
MEAT WITHHOLDING PERIOD NIL
MANUFACTURED BY:
Bioniche Teoranta, Republic of Ireland
Project:
File Name:
Size: As per Dieline - 6.75” w x 2.75” h x 0.85” d
Colours: CMYK Process
Date:
Artist:
Version:
ENHANCE I.A. / I.V. A/Asia SYRINGE carton
ENHANCE I.A. / I.V. A/Asia SYRINGE carton 2009
Jan 9, 2010
MLS
1.7
FIRST AID:
If pois

Summary of Product characteristics

PRODUCT NAME: ENHANCE® I.A./I.V. SODIUM HYALURONATE INJECTION FOR
HORSES
PAGE: 1 OF 5
THIS REVISION ISSUED: OCTOBER, 2015
SAFETY DATA SHEET
Issued by: Vetoquinol Australia Pty Ltd
Phone: [phone]
(BUSINESS HOURS)
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER
VETOQUINOL AUSTRALIA PTY LTD
PHONE: [phone]
(BUSINESS HOURS)
UNIT 302/2, 6-12 BORONIA ROAD, DA VINCI BUSINESS PARK,
FAX: [phone]
BRISBANE AIRPORT, QLD 4008
CHEMICAL NATURE:
Active ingredient is a high molecular weight mucopolysaccharide.
TRADE NAME:
ENHANCE
® I.A./I.V. SODIUM HYALURONATE INJECTION FOR HORSES
APVMA CODE:
53658
PRODUCT USE:
For treatment of non-infectious acute synovitis in horses by
intra-articular injection.
CREATION DATE:
APRIL, 2007
THIS VERSION ISSUED:
OCTOBER, 2015
and is valid for 5 years from this date.
POISONS INFORMATION CENTRE: PHONE 13 1126 FROM ANYWHERE IN AUSTRALIA
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to Australian Dangerous Goods (ADG)
Code, IATA and IMDG/IMSBC criteria.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
Not Hazardous - No criteria found.
SUSMP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
GHS SIGNAL WORD: NONE. NOT HAZARDOUS.
PREVENTION
P102: Keep out of reach of children.
P281: Use personal protective equipment as required.
RESPONSE
P337: If eye irritation persists: seek medical attention.
P352: Wash with plenty of soap and water.
P301+P330+P331: IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P370+P378: Not combustible. Use extinguishing media suited to burning
materials.
STORAGE
P410: Protect from sunlight.
P402+P404: Store in a dry place. Store in a closed container.
P403+P235: Store in a well-ventilated place. Keep cool.
DISPOSAL
P501: Dispose of co